La-Beck, Ninh M <br/><br/>
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jan 2012 
 - 43-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-011-1664-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Body Surface Area<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Monocytes--metabolism<br/>Neoplasms--drug therapy<br/>Polyethylene Glycols--administration & dosage<br/>Sarcoma, Kaposi--drug therapy<br/>Sex Factors